Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region-Reference-Cited by-同舟云学术

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region

Published:2015-04 Issue: Volume:116 Page:10-16
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Sarrazin Christoph,Lathouwers Erkki,Peeters Monika,Daems Bjorn,Buelens Annemie,Witek James,Wyckmans Yves^ORCID,Fevery Bart^ORCID,Verbinnen Thierry,Ghys Anne,Schlag Michael,Baldini Alessandra,De Meyer Sandra,Lenz Oliver

Funder

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference47 articles.

1. AASLD/IDSA Recommendations for Testing, Managing, and Treating Hepatitis C. Available at: http://www.hcvguidelines.org/full-report-view. Date accessed: 16th September 2014.

2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N. Engl. J. Med.,2014

3. Susceptibility of treatment-naive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitors;Bae;Antimicrob. Agents Chemother.,2010

4. Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies;Barnard;Virology,2013

5. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment;Bartels;J. Virol.,2013

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China;Infection, Genetics and Evolution;2024-09

2. Screening program in healthy individuals reveals a high prevalence of chronic hepatitis C in the general population of Austria;2024-01-30

3. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals;JHEP Reports;2022-05

4. Epistatic interactions promote persistence of NS3-Q80K in HCV infection by compensating for protein folding instability;Journal of Biological Chemistry;2021-09

5. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients;Current HIV Research;2021-09